MAGNOLIA CAPITAL ADVISORS LLC
Position in VKTX — Viking Therapeutics, Inc.
CIK 1803662
RIDGELAND, MS
Position in VKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$472,606
+$78,384 QoQ
Shares Held
12,115
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#226
of 434 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MAGNOLIA CAPITAL ADVISORS LLC holds $1,324,366 across 4 Biotechnology names. VKTX ranks #2 (35.7% of the industry book) .
All Filings in VKTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $472,606 | 12,115 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $394,222 | 12,115 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $426,276 | 12,117 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $311,864 | 11,867 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $314,502 | 11,868 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $286,539 | 11,865 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $444,853 | 11,055 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||